Organon & Co.

Pharmaceutical developer.

Based in NJ

🤖

AI Overview

With $95K in lobbying spend across 20 quarterly filings, Organon & Co is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2025.

$95K
Total Spend
5
Years Active
1
Firms Hired
10
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$10K
2022$20K
2023$20K
2024$25K
2025$20K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Organon & Co. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

General issues of interest to pharmaceutical companies.

General Issues of interest to pharmaceutical companies

Medicare reimbursement of pharmaceuticals

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.